John P. Cheatham, MD, Director of Cardiac Catheterization and Interventional Therapy and Co-director of The Heart Center at Nationwide Children's Hospital, has been named to the new class of Master Fellows of the Society for Cardiovascular Angiography and Interventions (MSCAI), the professional medical society for adult and pediatric invasive/interventional cardiologists. SCAI is recognized worldwide for its commitment to quality and education for enhancing the care of patients who suffer from all forms of congenital and acquired cardiovascular disease. The MSCAI recognition acknowledges outstanding SCAI members for a career achievement of excellence in patient care, teaching, research, and innovation.
“Master Fellow – or MSCAI – is a tremendous honor awarded a small number of SCAI Fellows, selected by their peers, as invasive/interventional cardiologists who have demonstrated leadership, clinical excellence and significant achievements over the course of their careers,” said James Blankenship, M.D., MHCM, FSCAI, 2015-16 SCAI President. “The MSCAI designation identifies the recipient is among the outstanding leaders and pioneers of our profession."
SCAI’s Master Interventionalists are department chairs, division chiefs, chairman of board of directors, organizational CEO’s, journal editors, and patent holders. Each has contributed indelibly not only to SCAI but extensively to the entire field of invasive/interventional cardiology. SCAI is indebted to their contributions and is now recognizing them appropriately for their accomplishments.
Dr. Cheatham holds the George H. Dunlap Endowed Chair in Interventional Cardiology. He is also a Professor of Pediatrics and Internal Medicine at The Ohio State University College of Medicine. After graduating from the University of Oklahoma College of Medicine, he completed his residency at Boston Children’s Hospital, followed by a fellowship in Pediatric Cardiology at Texas Children’s Hospital in Houston.
Dr. Cheatham’s area of expertise is transcatheter intervention and Hybrid therapy of newborns, children, and adults with complex congenital heart disease. He has pioneered several new techniques and devices in nonsurgical intervention, as well as being a world leader in developing new Hybrid therapies. He has been a principal investigator in numerous FDA sponsored clinical trials evaluating nonsurgical closure devices, stent therapy as well as transcatheter valve therapies over the past two decades.
Additionally, Dr. Cheatham designed the world’s first Hybrid Cardiac Catheterization Suites and advanced imaging equipment at Nationwide Children’s Hospital, which allows the interventionalist & cardiothoracic surgeon to perform combined therapy in order to improve clinical outcomes in patients referred to The Heart Center. He serves as a consultant to various medical companies and proctors, or teaches, new transcatheter techniques and devices to other physicians around the world. He recently performed First-in-Human Native Transcatheter Pulmonary Valve implantation as well as gene transfer therapy for limb-girdle muscular dystrophy.
Dr. Cheatham is co-director of the Nationwide Children’s Hospital International Program and has implemented a formal physician exchange program with two of the leading medical institutions in China. In cooperation with China Red Cross, he is also the Foreign Director of the International Training Center for treatment of congenital heart disease in poor children.
Dr. Cheatham has authored more than 175 manuscripts, 20 book chapters, more than 450 national and international presentations, and is co-editor of the book, “Complications in Percutaneous Interventions for Congenital and Structural Heart Disease.” He was selected as one of the top 25 Innovators in Healthcare by Health Imaging & IT. In addition, he was honored as the recipient of the Career Achievement Award at the prestigious 2007 PICS & AICS conference, attended by interventional cardiologists from all over the world.
The Master Fellows will continue to be recognized annually, and will comprise no more than 5 percent of SCAI’s membership. Those selected must have notable achievements in science, innovation, technical developments, teaching, leadership and the clinical practice of interventional cardiology, and have been an active member and Fellow of SCAI for at least 10 years.
The Society for Cardiovascular Angiography and Interventions is a 4,500-member professional organization representing invasive and interventional cardiologists in approximately 70 nations. SCAI's mission is to promote excellence in invasive/interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI's public education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit www.SCAI.org/ or www.SecondsCount.org. Follow @SCAI and @SCAINews on Twitter for the latest heart health news.
John P. Cheatham, MD, Co-director of The Heart Center at Nationwide Children's Hospital has been named to the new class of Master Fellows of the Society for Cardiovascular Angiography and Interventions.